Cytomegalovirus Infection
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-01Clinical Trial Update: MK-8228 (Letermovir) in the Prevention of Human Cytomegalovirus (CMV) Infection and Disease in Adult Japanese Kidney Transplant Recipients (MK-8228-042) [Phase 3]
Phase 3 trial MK-8228-042 evaluated letermovir for CMV prophylaxis in adult Japanese kidney transplant recipients; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030) [Phase 2]
Phase 2 pediatric study of letermovir for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation; results have b…
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults [Phase 2]
Phase 2 dose-finding trial completed evaluating safety and immunogenicity of the CMV vaccine mRNA-1647 in healthy adults.
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: A Study of CMV Vaccine (HB-101) in Kidney Transplant Patients [Phase 2]
Phase 2 trial evaluating CMV vaccine HB-101 in kidney transplant patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Letermovir Prophylaxis for Cytomegalovirus (CMV) in Patients With Graft-versus-host Disease [Phase 2]
Phase 2 trial update investigating letermovir prophylaxis for CMV in patients with graft-versus-host disease.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Letermovir for Primary Prophylaxis of Cytomegalovirus Infection After R+HID-HSCT [Phase 4]
Phase 4 clinical trial update for letermovir as primary prophylaxis of cytomegalovirus infection after R+HID-HSCT.
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant [Phase 2]
Phase 2 trial evaluating the multi-antigen CMV-MVA Triplex Vaccine to reduce cytomegalovirus complications in CMV-seropositive patients unde…
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Letermovir Versus Valganciclovir to Prevent Human Cytomegalovirus Disease in Kidney Transplant Recipients (MK-8228-002) [Phase 3]
Phase 3 trial comparing letermovir to valganciclovir for prevention of CMV disease in kidney transplant recipients has completed with result…
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants [Phase 3]
Phase 3 trial comparing maribavir to valganciclovir for cytomegalovirus infections in stem cell transplant recipients has completed with res…
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation. [Phase 2]
Phase 2 trial evaluating CMV-specific T cell therapy after allogeneic stem cell transplantation in hematologic malignancies with CMV infecti…
-
CLINICAL_TRIALS trial_result · 2022-11-01Clinical Trial Update: Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040) [Phase 3]
Phase 3 extension study assessing extending Letermovir prophylaxis from day 100 to day 200 after hematopoietic stem cell transplantation to …
-
CLINICAL_TRIALS trial_result · 2022-01-04Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ From a CMV-Seropositive Donor [Phase 2]
Phase 2 trial results assess the efficacy and safety of the ASP0113 CMV vaccine in CMV-seronegative kidney transplant recipients receiving a…
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults (V160-001) [Phase 1]
Phase 1 trial evaluating safety, tolerability, and immunogenicity of the human cytomegalovirus vaccine V160 in healthy adults has been compl…
-
CLINICAL_TRIALS trial_result · 2021-07-16Clinical Trial Update: Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipients [Phase 2]
Phase 2 trial update for CMX001 in preventing or controlling cytomegalovirus infection in CMV-seropositive hematopoietic stem cell transplan…
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss [Phase 2]
Phase 2 clinical trial evaluating valganciclovir therapy in infants and children with congenital cytomegalovirus infection and hearing loss …
-
CLINICAL_TRIALS trial_result · 2021-05-13Clinical Trial Update: Maribavir for Prevention of CMV After Stem Cell Transplants [Phase 2]
Phase 2 clinical trial update for maribavir in preventing CMV after stem cell transplant has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Randomized Clinical Trial, Open, Multicenter Parallel, no Suspension Inferiority Prophylactic Treatment With Valganciclovir in Kidney Transplant CMV-seropositive Cellular Immunity to Develop CD8 + CMV-specific Treatment After Induction Thymoglobulin. [Phase 3]
Phase 3 randomized trial evaluating valganciclovir prophylaxis in CMV-seropositive kidney transplant patients to influence thymoglobulin-ind…
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients [Phase 3]
Phase 3 trial update evaluating CMX001 for prevention of CMV infection in CMV-seropositive hematopoietic cell transplantation recipients has…
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 trial investigating donor-derived CMVpp65 specific T-cells for treatment of CMV infection or persistent CMV viremia after allogeneic…
-
CLINICAL_TRIALS trial_result · 2020-12-11Clinical Trial Update: Pre-engraftment Cytomegalovirus DNAemia
A completed clinical trial update for pre-engraftment CMV DNAemia, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-07-02Clinical Trial Update: CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL") [Phase 4]
Phase 4 clinical trial update on CMV antiviral prevention strategies in cytomegalovirus infection; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant [Phase 4]
Phase 4 trial in de novo kidney transplant recipients comparing Everolimus with very low tacrolimus to enteric-coated mycophenolate sodium w…
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: A Study in Adolescent Females to Explore Cytomegalovirus Infection [NA]
A completed clinical trial in adolescent females evaluating cytomegalovirus infection; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Study of SHP620 (Maribavir) in Healthy Adults [Phase 1]
Phase 1 trial update of SHP620 (Maribavir) in healthy adults has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-28Clinical Trial Update: A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT) [Phase 3]
A Phase 3 study evaluating ASP0113, a therapeutic vaccine, in CMV-seropositive recipients undergoing allogeneic hematopoietic cell transplan…